BR112017005762A2 - aprimoramentos na funcionalidade muscular de idosos do sexo masculino - Google Patents

aprimoramentos na funcionalidade muscular de idosos do sexo masculino

Info

Publication number
BR112017005762A2
BR112017005762A2 BR112017005762A BR112017005762A BR112017005762A2 BR 112017005762 A2 BR112017005762 A2 BR 112017005762A2 BR 112017005762 A BR112017005762 A BR 112017005762A BR 112017005762 A BR112017005762 A BR 112017005762A BR 112017005762 A2 BR112017005762 A2 BR 112017005762A2
Authority
BR
Brazil
Prior art keywords
muscle
male
functionality
muscle functionality
seniors
Prior art date
Application number
BR112017005762A
Other languages
English (en)
Other versions
BR112017005762B1 (pt
Inventor
Breuille Denis
Vinyes Pares Gerard
Moritani Toshio
Original Assignee
Nestec Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nestec Sa filed Critical Nestec Sa
Publication of BR112017005762A2 publication Critical patent/BR112017005762A2/pt
Publication of BR112017005762B1 publication Critical patent/BR112017005762B1/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
    • A23L2/385—Concentrates of non-alcoholic beverages
    • A23L2/39—Dry compositions
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
    • A23L2/52—Adding ingredients
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
    • A23L2/52—Adding ingredients
    • A23L2/66—Proteins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/185—Vegetable proteins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/19—Dairy proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/20—Milk; Whey; Colostrum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/01—Hydrolysed proteins; Derivatives thereof
    • A61K38/011—Hydrolysed proteins; Derivatives thereof from plants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/01—Hydrolysed proteins; Derivatives thereof
    • A61K38/012—Hydrolysed proteins; Derivatives thereof from animals
    • A61K38/018—Hydrolysed proteins; Derivatives thereof from animals from milk
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A23V2200/02—Antioxidant
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A23V2200/12—Replacer
    • A23V2200/13—Protein replacer
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A23V2200/30—Foods, ingredients or supplements having a functional effect on health
    • A23V2200/316—Foods, ingredients or supplements having a functional effect on health having an effect on regeneration or building of ligaments or muscles

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Nutrition Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Mycology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Botany (AREA)
  • Cell Biology (AREA)
  • Virology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Neurology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

a presente invenção refere-se a uma composição que compreende uma fonte de proteína e um antioxidante, opcionalmente em combinação com um ácido graxo ômega-3, que pode tratar ou prevenir a sarcopenia em idosos do sexo masculino, reduzir a perda da funcionalidade muscular (por exemplo, força muscular, velocidade de marcha, etc.) em idosos do sexo masculino, aumentar a funcionalidade muscular em idosos do sexo masculino e/ou melhorar a recuperação da funcionalidade muscular após atrofia muscular em idosos do sexo masculino.
BR112017005762-0A 2014-10-14 2015-10-09 Composição compreendendo uma fonte de proteína, e um antioxidante e seu uso BR112017005762B1 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201462063752P 2014-10-14 2014-10-14
US62/063,752 2014-10-14
PCT/EP2015/073361 WO2016058919A1 (en) 2014-10-14 2015-10-09 Improvement in muscle functionality of elderly males

Publications (2)

Publication Number Publication Date
BR112017005762A2 true BR112017005762A2 (pt) 2017-12-12
BR112017005762B1 BR112017005762B1 (pt) 2021-10-05

Family

ID=54293237

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112017005762-0A BR112017005762B1 (pt) 2014-10-14 2015-10-09 Composição compreendendo uma fonte de proteína, e um antioxidante e seu uso

Country Status (9)

Country Link
US (1) US20190111083A1 (pt)
EP (1) EP3206699B1 (pt)
JP (1) JP6826033B2 (pt)
CN (1) CN106793806A (pt)
AU (1) AU2015332935B2 (pt)
BR (1) BR112017005762B1 (pt)
CA (1) CA2963182C (pt)
ES (1) ES2960218T3 (pt)
WO (1) WO2016058919A1 (pt)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10744100B2 (en) 2015-11-17 2020-08-18 Societe Des Produits Nestle S.A. Compositions and methods using a polyphenol for musculoskeletal health
EP3376881B1 (en) 2015-11-17 2020-03-11 Société des Produits Nestlé S.A. Compositions and methods using a polyphenol for musculoskeletal health
JOP20190146A1 (ar) 2016-12-19 2019-06-18 Axcella Health Inc تركيبات حمض أميني وطرق لمعالجة أمراض الكبد
WO2018164251A1 (ja) * 2017-03-10 2018-09-13 株式会社明治 体力向上用組成物
JP7266581B2 (ja) 2017-08-14 2023-04-28 アクセラ・ヘルス・インコーポレイテッド 肝疾患の治療のためのアミノ酸組成物
CA3073021A1 (en) * 2017-08-16 2019-02-21 The Coca-Cola Company Beverage dispensing system for sports drinks with personalized hydration solutions
CN111315239A (zh) * 2017-11-21 2020-06-19 雀巢产品有限公司 针对肌肉质量和/或肌肉量使用橄榄苦苷或姜黄素的组合物和方法
US10596136B2 (en) 2018-06-20 2020-03-24 Axcella Health Inc. Compositions and methods for the treatment of fat infiltration in muscle
EP3818493A4 (en) 2018-07-06 2022-03-30 The Coca-Cola Company BEVERAGE DISPENSER NETWORK AND PROFILE MANAGEMENT
CN112888320A (zh) * 2018-11-05 2021-06-01 雀巢产品有限公司 使用姜黄素和ω-3脂肪酸的组合用于细胞能量的组合物和方法
CN109588709A (zh) * 2018-12-04 2019-04-09 沈阳师范大学 一种预防老年肌肉衰减的复合蛋白粉及制备方法
FR3093404B1 (fr) * 2019-03-08 2023-04-14 Jean Marc Tachet Creation Procédé d’enrichissement d’aliments en protéines et/ou en compléments alimentaires
CN113367349B (zh) * 2020-02-25 2024-03-12 内蒙古蒙牛乳业（集团）股份有限公司 用于肌肉衰减综合征的组合物、其制备方法和用途
CN111972672A (zh) * 2020-08-25 2020-11-24 黑龙江省完达山乳业股份有限公司 一种具有增加肌肉功能的组合物及其应用
WO2022052017A1 (en) * 2020-09-11 2022-03-17 Liu Hsuan Miao Pharmaceutical compositions and uses thereof in treating muscle atrophy
CN115177000A (zh) * 2021-04-07 2022-10-14 陕西罗麻丹医药有限公司 一种改善老年肌少症的粉剂及其制备方法
WO2023012371A1 (en) 2021-08-06 2023-02-09 N.V. Nutricia Nutritional composition for muscle mass, strength and function

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7966922B2 (en) * 2007-05-24 2011-06-28 Lockheed Martin Corporation Electro-magnetic restraint
US7790688B2 (en) * 2008-01-11 2010-09-07 Healthspan Solutions, Llc Compositions and methods for increasing muscle mass, strength, and functional performance in the elderly
WO2010143939A1 (en) * 2009-06-09 2010-12-16 N.V. Nutricia Nutrition for improving muscle strength in elderly
SG177664A1 (en) * 2009-07-20 2012-02-28 Nestec Sa Methods of attenuating the loss of functional status
EP2311486A1 (en) * 2009-10-07 2011-04-20 Nestec S.A. GLP-2 for use in intestine and muscle recovery
IN2012DN06588A (pt) * 2010-02-10 2015-10-23 Novartis Ag
JP5983601B2 (ja) * 2011-04-13 2016-08-31 味の素株式会社 栄養組成物
MX2013012228A (es) * 2011-04-18 2013-12-06 Nestec Sa Composiciones nutricionales que tienen a-hica y metodos para utilizar las mismas.
EP2580967A1 (en) * 2011-10-11 2013-04-17 Nestec S.A. Accelerating muscle recovery after immobilization-induced muscle atrophy
WO2014028607A1 (en) 2012-08-14 2014-02-20 Abbott Laboratories Low glycemic index nutritional compositions for preserving muscle mass and improving body composition in diabetics
ES2617714T5 (es) * 2013-04-15 2021-02-11 Nestle Sa Empleo de la proteína de suero en combinación con la estimulación eléctrica muscular
WO2014191856A1 (en) * 2013-05-31 2014-12-04 Nestec S.A. Methods for enhancement of muscle protein synthesis

Also Published As

Publication number Publication date
WO2016058919A1 (en) 2016-04-21
CN106793806A (zh) 2017-05-31
CA2963182C (en) 2023-10-17
BR112017005762B1 (pt) 2021-10-05
EP3206699B1 (en) 2023-09-13
JP2017536336A (ja) 2017-12-07
US20190111083A1 (en) 2019-04-18
AU2015332935B2 (en) 2020-11-26
JP6826033B2 (ja) 2021-02-03
EP3206699A1 (en) 2017-08-23
ES2960218T3 (es) 2024-03-01
CA2963182A1 (en) 2016-04-21
AU2015332935A1 (en) 2017-03-09

Similar Documents

Publication Publication Date Title
BR112017005762A2 (pt) aprimoramentos na funcionalidade muscular de idosos do sexo masculino
CO2017013443A2 (es) Composiciones que comprenden cepas bacterianas del género blautia
BR112018010211A2 (pt) formulação farmacêutica aquosa compreendendo anticorpo anti-pd-l1 avelumab
BR112019000338A2 (pt) composições compreendendo cepas bacterianas
CL2018001368A1 (es) Composiciones que comprenden cepas bacterianas
CO2017013446A2 (es) Composiciones que comprenden cepas bacterianas del género bacteroides
CL2018001349A1 (es) Composiciones que comprenden cepas bacterianas
CL2018001367A1 (es) Composiciones que comprenden cepas bacterianas
BR112018003184A2 (pt) absorvente feminino com braçadeiras de barreira
CL2016000839A1 (es) Composiciones para modular la expresión de c9orf72.
BR112017013858A2 (pt) n4-hidroxicitidina e derivados e usos antivirais relacionados aos mesmos
BR112016023851A2 (pt) ?composição de revestimento de duas partes e método para revestir uma superfície?
CL2016002971A1 (es) Combinación.
CL2017001438A1 (es) Antagonistas de miostatina o activina para el tratamiento de sarcopenia
BR112017002370A2 (pt) indóis para uso na infecção pelo vírus da gripe
BR112017004524A2 (pt) pirrolopirimidinas para uso na infecção pelo vírus da gripe
BR112018003745A2 (pt) composições que compreendem um composto de urolitina
BR112016022593A2 (pt) composições e métodos para modular a expressão do fator b do complemento
BR112018003780A2 (pt) composições que compreendem um composto de urolitina
BR112018007958A2 (pt) composições e métodos que usam um polifenol para a saúde musculoesquelética
BR112017018620A2 (pt) método de administração de tradipitanto, e, tradipitanto.
AR102085A1 (es) Composición nutricional para el entorno gastrointestinal para la provisión de un perfil metabólico y microbioma mejorados
BR112016023754A2 (pt) ?uso de lactobacillus paracasei para promover recuperação da diversidade da microbiota intestinal após disbiose?
BR112018000786A2 (pt) métodos e composições usando bifidobacterium longum para modular a reatividade emocional e tratar ou evitar perturbações subclínicas do estado de humor
BR112017025639A2 (pt) brinquedo de transformação

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]

Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NO 10196/2001, QUE MODIFICOU A LEI NO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUENCIA PREVIA DA ANVISA. CONSIDERANDO A APROVACAO DOS TERMOS DO PARECER NO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDENCIAS CABIVEIS.

B25A Requested transfer of rights approved

Owner name: SOCIETE DES PRODUITS NESTLE S.A. (CH)

B07G Grant request does not fulfill article 229-c lpi (prior consent of anvisa) [chapter 7.7 patent gazette]
B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B350 Update of information on the portal [chapter 15.35 patent gazette]
B350 Update of information on the portal [chapter 15.35 patent gazette]
B09W Correction of the decision to grant [chapter 9.1.4 patent gazette]

Free format text: REFERENTE AO DESPACHO 9.1 NOTIFICADO NA RPI NO 2639, DE 03/08/2021

B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 09/10/2015, OBSERVADAS AS CONDICOES LEGAIS.